Source: International Congress 2015 – IPF: clinical aspects
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hwang In Kyoung (Seoul , Republic of Korea), In Kyoung Hwang, Seon Hye Kim, Myung Jae Park, Hong Mo Kang. Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF). Eur Respir J 2015; 46: Suppl. 59, 2041

Member's Comments

No comment yet.

Related content which might interest you: A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Analysis of oxygen saturation (O2 sat.) During the six minutes walk distance (6MWD) test in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases Year: 2009 The six minute walk test (6MWT) can predict O2 flows required to prevent exercise induced O2 desaturation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 The reliability and validity of the 4 metre gait speed (4MGS) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases Year: 2016 Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016 Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF) – test of a new approach Source: Eur Respir J 2007; 30: Suppl. 51, 580s Year: 2007 Challenges in idiopathic pulmonary fibrosis trials: the point on end-points Source: Eur Respir Rev 2011; 20: 195-200 Year: 2011 The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 25: 96-103 Year: 2005 The six minute walking test: Clinical predictors of survival in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Echocardiographic findings in severe chronic obstructive pulmonary disease (COPD) patients who desaturate during 6-minute walking test (6MWT) Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 Correlation of composite physiologic index with 6-minute walk test variables in patients with idiopathic interstitial pneumonias Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 Relationship of cardiopulmonary exercise testing (CPET) and lung function in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 120s Year: 2007 Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability Source: Annual Congress 2008 - Rehabilitation and influencing factors Year: 2008 Sex differences in physiological progression of idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 31: 1183-1188 Year: 2008 Clinical predictors of pulmonary hypertension in sarcoidosis Source: Eur Respir J 2008; 32: 296-302 Year: 2008 FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change Source: Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019 Year: 2020 Change in 6-minute walk test can predict prognosis in idiopathic pulmonary fibrosis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 What is the role of hypoxaemia, 6-minute walk test, diffusion capacity, pulmonary arterial hypertension in diffuse interstitial lung diseases? Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Resting DLCO predictis exercise lung gas exchange efficiency but not walking distance at 6‘WT in idiopathic pulmonary artery hypertension (IPAH) Source: Eur Respir J 2005; 26: Suppl. 49, 106s Year: 2005